Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Huntington Disease.

Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 148,600 shares, ...

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease.

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a mouse model of ...

Researchers at the University of Illinois have found that a gene editing tool allows them to “skip” genes that lead to ...

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta plaque precursors in a mouse model of ...

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce ...

Coronation Street star Denise Welch has judged a gingerbread man competition at Silverbirch House care home in Worplesdon.

Patients with ankylosing spondylitis are associated with an increased risk of developing neurodegenerative diseases, ...